Article
The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
BMC cancer - 17 Nov 2022
Ke Liyuan, Li Su, Cui Hongxia
Abstract excerpt
BACKGROUND: As a potential genetic biomarker, tumor mutation burden (TMB) has made progress in numerous tumors. There are limited data regarding TMB and its prognostic role is controversial in breast cancer. This systematic review and meta-analysis were conducted to assess the prognostic value of TMB on survival of breast cancer. METHODS: The databases PubMed, Embase, Web of Science, and Cochrane Library were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
